HUTCHMED (China) (HMDCF) Change in Accured Expenses (2015 - 2025)
HUTCHMED (China) (HMDCF) reported Change in Accured Expenses of $221.1 million for Q2 2025, up 593.44% year-over-year from $31.9 million in Q2 2024, and down 99.33% quarter-over-quarter from $32.9 billion in Q4 2024.
HUTCHMED (China) (HMDCF) Change in Accured Expenses (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HMDCF) has 11 years of Change in Accured Expenses data on file, last reported at $221.1 million in Q2 2025.
- Change in Accured Expenses for Q2 2025 came in at $221.1 million, up 593.44% year-over-year; the trailing twelve-month figure through Jun 2025 was $221.1 million (up 593.44% YoY), and the FY2024 annual result was $2.4 million, up 155.18% from the prior year.
- Change in Accured Expenses retreated to $221.1 million in Q2 2025 per HMDCF's latest filing, from $32.9 billion in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $34.7 billion in Q4 2023 and troughed at $9.9 million in Q1 2021.
- A 5-year average of $6.8 billion and a median of $107.7 million in 2021 frame the typical range for Change in Accured Expenses.
- On a YoY basis, Change in Accured Expenses climbed as much as 102575.61% in 2023 and fell as far as 87.59% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at $27.1 million in 2021, then increased by 24.98% to $33.8 million in 2022, then surged by 102575.61% to $34.7 billion in 2023, then slipped by 5.15% to $32.9 billion in 2024, then slumped by 99.33% to $221.1 million in 2025.
- Business Quant data shows HMDCF's Change in Accured Expenses at $221.1 million in Q2 2025, $32.9 billion in Q4 2024, and $31.9 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | HUTCHMED (China) | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 221.06 Mn |
| Jun 30, 2025 | 221.06 Mn |
| Dec 31, 2024 | 32.95 Bn |
| Dec 31, 2024 | 32.95 Bn |
| Jun 30, 2024 | 31.88 Mn |
| Jun 30, 2024 | 31.88 Mn |
| Dec 31, 2023 | 34.73 Bn |
| Dec 31, 2023 | 34.73 Bn |
| Jun 30, 2023 | 28.98 Mn |
| Jun 30, 2023 | 28.98 Mn |
| Dec 31, 2022 | 33.83 Mn |
| Dec 31, 2022 | 33.83 Mn |
| Jun 30, 2022 | 233.61 Mn |
| Jun 30, 2022 | 233.61 Mn |
| Dec 31, 2021 | 27.07 Mn |
| Dec 31, 2021 | 27.07 Mn |
| Jun 30, 2021 | 181.61 Mn |
| Jun 30, 2021 | 181.61 Mn |
| Mar 31, 2021 | 9.94 Mn |
| Mar 31, 2021 | 9.94 Mn |